Cargando…
NTRK Fusions in 1113 Solid Tumors in a Single Institution
SIMPLE SUMMARY: Recently, there has been increasing interest in identifying NTRK fusions in various tumors, as they are therapeutically targetable driver mutations. In tumor types with low-frequency NTRK fusions, recent recommendations on NTRK testing recommend pan-Trk immunohistochemistry (IHC) as...
Autores principales: | Bang, Heejin, Lee, Mi-Sook, Sung, Minjung, Choi, Juyoung, An, Sungbin, Kim, Seok-Hyung, Lee, Seung Eun, Choi, Yoon-La |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222038/ https://www.ncbi.nlm.nih.gov/pubmed/35741260 http://dx.doi.org/10.3390/diagnostics12061450 |
Ejemplares similares
-
Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing
por: An, Sungbin, et al.
Publicado: (2022) -
Interlaboratory Comparison Study (Ring Test) of Next-Generation Sequencing–Based NTRK Fusion Detection in South Korea
por: Lee, Seung Eun, et al.
Publicado: (2023) -
NTRK1 Fusion in Glioblastoma Multiforme
por: Kim, Jinkuk, et al.
Publicado: (2014) -
Prevalence of NTRK Fusions in Canadian Solid Tumour Cancer Patients
por: Silvertown, Joshua D., et al.
Publicado: (2022) -
Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors
por: Kang, Jeongwan, et al.
Publicado: (2020)